Loman, N. et al. 2025. Predicting neoadjuvant chemotherapy treatment response in hormone- receptor-positive/HER2-negative breast cancer – results from the Swedish SCAN-B population-based cohort. Acta Oncologica. 64, (Nov. 2025), 1577–1589. DOI:https://doi.org/10.2340/1651-226X.2025.44201.